Your session is about to expire
← Back to Search
Focused Muscle Contraction Therapy
Focused Muscle Contraction Therapy for Veteran Wellbeing
N/A
Recruiting
Led By Enrico Benedetti, MD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years of age and older
Be older than 18 years old
Must not have
Unable to give consent
Unable to travel to the training center
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will investigate whether the GH Method exercise program can improve the overall sense of wellbeing in U.S. Veterans.
Who is the study for?
This trial is for U.S. Veterans over 18 who are patients at the Jesse Brown VA Medical Center, experiencing pain, fatigue, or reduced ability to perform activities. They must pass a health questionnaire or have doctor's clearance and be able to travel to the training center and comply with the program.
What is being tested?
The study tests if the GH Method exercise program can improve body composition, physical abilities, and wellbeing in veterans dealing with issues like depression or PTSD. It requires four fitness testing visits and ninety exercise sessions at GH FITLab over 18 months.
What are the potential side effects?
While not explicitly listed, potential side effects may include muscle soreness, increased pain or fatigue from new exercises. Psychological distress could also occur when addressing sensitive topics in questionnaires.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable to understand and give consent for treatment.
Select...
I cannot travel to the training center.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Heart rate
Secondary study objectives
Rate at which subjects enrolled in the exercise intervention will have an overall change in pain intensity.
Rate at which subjects enrolled in the exercise intervention will have an overall changed in fatigue.
Rate at which subjects enrolled in the exercise intervention will have an overall changed in their quality of life.
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Investigate the effects of an exercise intervention on U.S. Veterans.Experimental Treatment1 Intervention
A total of 25 U.S. Veterans (≥ 18 years of age), who suffer from pain, fatigue, low energy levels or are unable to physically do things they were once able to do, will be enrolled.
Find a Location
Who is running the clinical trial?
University of Illinois at ChicagoLead Sponsor
640 Previous Clinical Trials
1,568,683 Total Patients Enrolled
3 Trials studying Chronic Pain
808 Patients Enrolled for Chronic Pain
Enrico Benedetti, MDPrincipal InvestigatorUniversity of Illinois at Chicago
2 Previous Clinical Trials
39 Total Patients Enrolled
1 Trials studying Chronic Pain
15 Patients Enrolled for Chronic Pain
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I experience pain, fatigue, or struggle with daily activities.I have passed a fitness assessment or have doctor's approval for physical activity.I am unable to understand and give consent for treatment.I cannot travel to the training center.Military veterans from the United States
Research Study Groups:
This trial has the following groups:- Group 1: Investigate the effects of an exercise intervention on U.S. Veterans.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.